MedTrace Logo

Effect of Strength Training and Protein Ingestion in Old Versus Very-old

NCT02105922 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2018-02-28

No results posted yet for this study

Summary

From 3 interventiongroups in the project with ClinicalTrials.gov ID NCT02034760, namely:

HRTW: Heavy Strength Training x3/week \& 20g whey protein twice daily. LITW: Light Intensity Training x3-5/week \& 20g whey protein twice daily. WHEY: 20g whey protein twice daily.

15 subjects from each group will be recruited and tested after 3 months of intervention. Tests will include muscle cross sectional area (MRi), muscle biopsies (fiber types, size, cell- and capillary count), functional- and strength measurements, plasma lipids, HbA1c. Tests are to be compared with Project ID NCT01997320.

Conditions

Interventions

PROCEDURE

Heavy Resistance Training

Supervised Heavy Resistance Training three times weekly for 3 months.

PROCEDURE

Light Intensity Training

Home-based Light Intensity Training three-five times weekly for 3 months.

PROCEDURE

Protein Whey

Two daily 20g whey protein and 10g carbohydrate supplementations for 3 months.

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • Arla Foods

    collaborator INDUSTRY

  • Bispebjerg Hospital

    lead OTHER

Principal Investigators

  • Rasmus Bechshøft, Ph.d. · Bispebjerg Hospital

  • Lars Holm, Assoc. prof. · Bispebjerg Hospital

  • Michael Kjær, MD, Proff. · Bispebjerg Hospital

  • Søren Reitelseder, Ph.d. · Bispebjerg Hospital

  • Jacob Bülow, MD PhD stud · Bispebjerg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-01
Primary Completion
2016-03-30
Completion
2016-03-30

Countries

  • Denmark

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02105922 on ClinicalTrials.gov